Clinical Trial
doi: 10.1111/j.1365-4362.1986.tb03461.x.
Cryotherapy in acute cutaneous leishmaniasis
- PMID: 3533799
- DOI: 10.1111/j.1365-4362.1986.tb03461.x
Item in Clipboard
Clinical Trial
Cryotherapy in acute cutaneous leishmaniasis
Int J Dermatol.
1986 Sep.
Abstract
Fourteen patients with acute cutaneous leishmaniasis entered a study testing the efficacy of liquid nitrogen. All lesions were cured clinically and protozoologically within 3-8 weeks, without noticeable scarring. The patients did not experience adverse side effects, and there was no relapse 4 months after cessation of therapy. The results of this study indicate that cryotherapy is a safe and effective method for treating cutaneous leishmaniasis.
Similar articles
-
Cryosurgery in cutaneous leishmaniasis.Br J Dermatol. 1982 Oct;107(4):467-74. doi: 10.1111/j.1365-2133.1982.tb00390.x. Br J Dermatol. 1982. PMID: 7126453
-
Cryosurgery for cutaneous leishmaniasis.J Dermatol Surg Oncol. 1983 May;9(5):354-6. doi: 10.1111/j.1524-4725.1983.tb00815.x. J Dermatol Surg Oncol. 1983. PMID: 6841786 No abstract available.
-
Efficacy of a weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis.J Am Acad Dermatol. 2008 Apr;58(4):617-24. doi: 10.1016/j.jaad.2007.12.032. Epub 2008 Feb 4. J Am Acad Dermatol. 2008. PMID: 18249466
-
[Cutaneous leishmaniasis: treatment with cryotherapy and intramuscular injections of meglumine antimonate (glucantime)].Hautarzt. 1990 Feb;41(2):98-101. Hautarzt. 1990. PMID: 2318646 German.
-
Safety and efficacy of current alternatives in the topical treatment of cutaneous leishmaniasis: a systematic review.Parasitology. 2017 Jul;144(8):995-1004. doi: 10.1017/S0031182017000385. Epub 2017 Apr 3. Parasitology. 2017. PMID: 28367792 Review.
Cited by
-
Systems biology of autophagy in leishmanial infection and its diverse role in precision medicine.Front Mol Biosci. 2023 Apr 21;10:1113249. doi: 10.3389/fmolb.2023.1113249. eCollection 2023. Front Mol Biosci. 2023. PMID: 37152895 Free PMC article. Review.
-
Using Q-methodology to understand the perspectives and practical experiences of dermatologists about treatment difficulties of cutaneous leishmaniasis.BMC Infect Dis. 2020 Sep 1;20(1):645. doi: 10.1186/s12879-020-05365-0. BMC Infect Dis. 2020. PMID: 32873242 Free PMC article.
-
Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development.Expert Opin Drug Metab Toxicol. 2019 Jul;15(7):595-612. doi: 10.1080/17425255.2019.1629417. Epub 2019 Jun 17. Expert Opin Drug Metab Toxicol. 2019. PMID: 31174439 Free PMC article. Review.
-
Interventions for Old World cutaneous leishmaniasis.Cochrane Database Syst Rev. 2017 Dec 1;12(12):CD005067. doi: 10.1002/14651858.CD005067.pub5. Cochrane Database Syst Rev. 2017. PMID: 29192424 Free PMC article. Review.
-
Interventions for Old World cutaneous leishmaniasis.Cochrane Database Syst Rev. 2017 Nov 17;11(11):CD005067. doi: 10.1002/14651858.CD005067.pub4. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2017 Dec 01;12:CD005067. doi: 10.1002/14651858.CD005067.pub5. PMID: 29149474 Free PMC article. Updated. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
